Ally Bridge Group (NY) LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001822947

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2025 · 24 positions · Total reported value $120.18M · Top-10 concentration 65.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 86.5% · 11 new · 9 cut · 12 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.2% · vs SPY +7.4% · Prev Value $117.12M — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2025 13F filing, Ally Bridge Group (NY) LLC disclosed 24 equity positions with a combined reported value of $120.18M. The filing implies a focused portfolio: its ten largest positions account for 65.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were VRNA ($15.20M), SLNO ($14.98M), LENZ ($10.06M). By sector, the heaviest allocations are Health Care 58.5%, Other 41.5%. Versus the prior quarter, allocation shifted toward Health Care (+3.8pp) and away from Other (-3.8pp).

Versus the prior quarter, Ally Bridge Group (NY) LLC opened 11 new positions, trimmed 9 and fully exited 12, a turnover rate of 86.5% of positions. The portfolio's overlap with the prior quarter was 43% of names.

The largest new positions opened in Q2 2025 were LENZ ($10.06M), RARE ($5.82M), ORIC ($4.93M).

Of the 12 positions fully exited versus the prior quarter, the largest were SWTX ($12.41M), BPMC ($6.57M), AXSM ($5.83M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • LENZ LENZ THERAPEUTICS INC · $10.06M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · $5.82M
  • ORIC ORIC PHARMACEUTICALS INC · $4.93M
  • REPL REPLIMUNE GROUP INC · $4.91M
  • CMPS COMPASS PATHWAYS ADR A FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS · $4.16M
  • RNAM AVIDITY BIOSCIENCES INC · $3.77M
  • SLDB SOLID BIOSCIENCES INC COM NEW · $3.53M
  • LXEO LEXEO THERAPEUTICS INC COM · $3.49M

Fully Exited (vs previous quarter)

  • SWTX SPRINGWORKS THERAPEUTICS INC · prev qtr: $12.41M
  • BPMC BLUEPRINT MEDICINES CORP · prev qtr: $6.57M
  • AXSM AXSOME THERAPEUTICS INC. · prev qtr: $5.83M · history
  • TRVI TREVI THERAPEUTICS INC COM · prev qtr: $4.32M
  • CGON CG ONCOLOGY INC · prev qtr: $3.24M
  • XENE XENON PHARMACEUTICALS INC · prev qtr: $2.34M
  • EWTX EDGEWISE THERAPEUTICS INC · prev qtr: $2.20M · history
  • JANX JANUX THERAPEUTICS INC · prev qtr: $2.19M

Insider Transactions (Form 4)

Latest Ally Bridge Group (NY) LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Ally Bridge Group (NY) LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 25 US equity positions with a combined value of $113.07M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-121984 (status: Approved), registered 2021-07-30
  • Regulatory AUM (Form ADV): $218.95M as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds

Portfolio Structure

  • 25 positions · $113.07M reported value (Q2 2026)
  • Top 10 holdings = 70.5% of reported value
  • Largest position: DFTX (DEFINIUM THERAPEUTICS F) at 16.6%
  • Average position size: $4.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 11 new, 3 added, 9 reduced, 12 exited
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 58.5%
Other 41.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 160.70K $15.20M 12.65%
12.65%
Add
2 178.82K $14.98M 12.47%
12.47%
Add
3 343.32K $10.06M 8.37%
8.37%
New
4 140.21K $7.37M 6.14%
6.14%
Add
5 1.60K $5.82M 4.84%
4.84%
New
6 281.39K $5.64M 4.70%
4.70%
Add
7 485.63K $4.93M 4.10%
4.10%
New
8 528.49K $4.91M 4.08%
4.08%
New
9 121.18K $4.91M 4.08%
4.08%
Reduce
10 47.71K $4.80M 4.00%
4.00%
Reduce
11 726.17K $4.71M 3.92%
3.92%
Add
12 3.25M $4.58M 3.81%
3.81%
Add
13 1.49M $4.16M 3.46%
3.46%
New
14 293.99K $3.86M 3.21%
3.21%
Add
15 132.74K $3.77M 3.14%
3.14%
New
16 724.00K $3.53M 2.93%
2.93%
New
17 867.30K $3.49M 2.90%
2.90%
New
18 80.88K $3.40M 2.83%
2.83%
Reduce
19 163.68K $3.25M 2.71%
2.71%
Add
20 154.22K $1.93M 1.60%
1.60%
Add
21 817.94K $1.53M 1.27%
1.27%
Hold
22 287.72K $1.46M 1.21%
1.21%
Reduce
23 34.54K $1.24M 1.03%
1.03%
New
24 1.33M $645.60K 0.54%
0.54%
Reduce

FAQ

What did Ally Bridge Group (NY) LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, Ally Bridge Group (NY) LLC reported 24 equity positions worth $120.18M in aggregate; its largest disclosed positions were VRNA ($15.20M), SLNO ($14.98M), LENZ ($10.06M).

How large is Ally Bridge Group (NY) LLC's portfolio?

Ally Bridge Group (NY) LLC reported $120.18M of long equity holdings across 24 positions as of 2025-Q2. Top-10 holdings account for 65.4% of reported value.

What is Ally Bridge Group (NY) LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ally-bridge-group-ny/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →